Politics

Politics By Lev Facher

Q&A: Vivek Murthy, a top Biden adviser, on Covid-19 vaccines, the drug industry, and the future of public health

Politics By Lev Facher

A Senate race in Kansas between two doctors sets the stage for an election hyper-focused on health policy — and on Covid-19

Special Report By Lev Facher

Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus

Politics By Lev Facher

Trump urges people to avoid discretionary travel and limit gatherings to fewer than 10 people

Politics By Lev Facher

House Republicans fuel Capitol Hill chaos with competing drug pricing bill

Pharmalot By Ed Silverman

Pharmalittle: Purdue bankruptcy sets tone for opioid cases; Sanders criticizes Biden for praising pharma

Politics By Lev Facher and Ed Silverman

VA declines broad coverage for new J&J depression drug touted by Trump

Pharma By Priyanka Dayal McCluskey — Boston Globe

WHO rescinds opioid guidelines following criticism by two U.S. lawmakers

Politics By Megan Thielking

A new push aims to bring mental health and addiction into the 2020 campaign conversation

Politics By Lev Facher

These Republicans campaigned on a bold drug-pricing pledge. Since they won, they’ve gone silent

Politics By Nicholas Florko

How do you improve Medicare? Maybe you watch Major League Baseball

The Pharmalot View By Ed Silverman

Tweet this: Gottlieb’s leaving, and so is FDA’s highly effective communicator

Politics By Lev Facher and Nicholas Florko

Webinar: Is the new Congress ready to lower drug costs?

Politics By Rick Berke

A letter from Executive Editor Rick Berke: All eyes on today’s drug pricing hearing

Politics By Nicholas Florko

Defending the middlemen: JC Scott on testifying before Congress, challenging Trump, and revamping PBMs’ image

Heavyweights By Rick Berke

Billionaire Sean Parker calls China’s gene-edited babies ‘Sputnik 2.0,’ praises FDA, and offers career advice for millennials

Biotech By Damian Garde, Rebecca Robbins and Adam Feuerstein

A tweet from Alexandria Ocasio-Cortez prompts a deeper debate over how drugs are made

Pharmalot By Ed Silverman

Sanders accuses a drug maker of ‘immoral exploitation’ for the price of a rare disease drug

Pharmalot By Ed Silverman

Here’s how Massachusetts officials hope to lower their Medicaid drug spending

Politics By Robert Weisman — Boston Globe

Drug costs plague seniors, but legislative relief may be elusive

Politics By Lev Facher

3 state legislative battles to watch in 2019

Pharmalot By Ed Silverman

Big drug makers are socking away more cash lately thanks to the tax overhaul, and it’s likely to be used for more deals

Donald Trump speaks prior to signing bills intended to lower prescription drug prices

Politics By Nicholas Florko

Trump will give speech on drug prices Thursday

Pharmalot By Ed Silverman

New U.S. trade deal with Canada and Mexico is criticized for provisions affecting drug prices

Pharmalot By Elizabeth Cooney

Most Read

Elbow bumps, social distancing, and Medicare for All: The coronavirus pandemic dominated every aspect of the Democratic debate

‘Reject Big Pharma’: Anti-vaccine activists co-opt a populist slogan to try to repeal a state immunization law

Trump taps Pence to lead U.S. coronavirus response

As medical professionals, my husband and I know the Nigerian travel ban is cruel. Now the pain is personal

In their words: Warren, Buttigieg, Klobuchar, and other Democrats explain exactly how they’d lower drug prices

In Germany, pharma groups greet Trump’s remarks with scorn

More than a dozen Democrats are bringing people with sky-high insulin bills to the State of the Union

More doctors need to vote and get politically involved

All Coverage

Q&A: Vivek Murthy, a top Biden adviser, on Covid-19 vaccines, the drug industry, and the future of public health

A Senate race in Kansas between two doctors sets the stage for an election hyper-focused on health policy — and on Covid-19

Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus

Trump urges people to avoid discretionary travel and limit gatherings to fewer than 10 people

House Republicans fuel Capitol Hill chaos with competing drug pricing bill

Pharmalittle: Purdue bankruptcy sets tone for opioid cases; Sanders criticizes Biden for praising pharma

VA declines broad coverage for new J&J depression drug touted by Trump

WHO rescinds opioid guidelines following criticism by two U.S. lawmakers

A new push aims to bring mental health and addiction into the 2020 campaign conversation

These Republicans campaigned on a bold drug-pricing pledge. Since they won, they’ve gone silent

How do you improve Medicare? Maybe you watch Major League Baseball

Tweet this: Gottlieb’s leaving, and so is FDA’s highly effective communicator

Webinar: Is the new Congress ready to lower drug costs?

A letter from Executive Editor Rick Berke: All eyes on today’s drug pricing hearing

Defending the middlemen: JC Scott on testifying before Congress, challenging Trump, and revamping PBMs’ image

Billionaire Sean Parker calls China’s gene-edited babies ‘Sputnik 2.0,’ praises FDA, and offers career advice for millennials

A tweet from Alexandria Ocasio-Cortez prompts a deeper debate over how drugs are made

Sanders accuses a drug maker of ‘immoral exploitation’ for the price of a rare disease drug

Here’s how Massachusetts officials hope to lower their Medicaid drug spending

Drug costs plague seniors, but legislative relief may be elusive

3 state legislative battles to watch in 2019

Big drug makers are socking away more cash lately thanks to the tax overhaul, and it’s likely to be used for more deals

Trump will give speech on drug prices Thursday

New U.S. trade deal with Canada and Mexico is criticized for provisions affecting drug prices

Pharmalittle: Markups on generics are growing; drug-pricing rhetoric heats up

Most Read

All Coverage